Malignant Breast Neoplasm — Trials

Malignant Breast Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,627
Recruiting: 1,400
Ph III recruiting: 154
Growth YoY: +20.8%
Industry share: 18%
Top sponsor: Fudan University
Termination share: 25.6%
Trials / 1,000 deaths: 61.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,368)

clinicaltrialsPublishedShowing 151–200 of 480 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03071926	Metronomic PLD in Patients With Primary Endocrine Resistant ABC	unknown	Phase 2	46	Fudan UniversityOTHER	1	Apr 20, 2022	clinicaltrials
NCT04192903	Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast Cancer	unknown	Phase 2	55	Fudan UniversityOTHER	1	Apr 20, 2022	clinicaltrials
NCT04609215